Ideally the best way to test our reasoning and rationale is to compare the ALDH2 activity in ovarian cancer stem cells with the killing rate of chemotherapy for ovarian cancer stem cells or compare the ALDH2 activity in ovarian stem cells with the ovarian cancer incidence. This evidence concerns the gene ALDH2 and ovarian carcinoma.